Form 8.3 - [SPIRENT COMMUNICATIONS PLC] - 24 04 2024 - (CGAML)
GlobeNewswire
*FORM 8.3*
*PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY *
*A PERSON WITH INTERESTS IN RELEVANT..
*FORM 8.3*
*PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY *
*A PERSON WITH INTERESTS IN RELEVANT..
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage..
*FORM 8.3*
*PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY *
*A PERSON WITH INTERESTS IN RELEVANT..